Learn more about the newest member to join our global community: MultiplAI. It is a company based in London focused on developing precision medicine technology.
MultiplAI Health is a London-based techbio company with the vision to provide universal access to genomic screening for cardiovascular and other complex diseases. Our current focus is developing a groundbreaking AI-driven RNA-based blood test to revolutionise screening for cardiovascular disease (CVD), the leading cause of global mortality, claiming 18 million lives annually. MultiplAI has a laboratory-validated product, is conducting clinical studies to generate proprietary data and is aiming for US commercial market entry by 2024. MultiplAI is based in the UK with additional operations in the USA, Spain and Argentina.
As a TechBio company focused on developing precision medicine technology to revolutionise screening for complex diseases, we are focused on providing solutions to several areas in the healthcare space including private and public primary care, government healthcare systems and pharma.
As a young health technology company, a core focuses for MultiplAI is on developing partnerships to further our research efforts and build relationships that will assist us in further funding opportunities.
